Synapse

Synapse, by PatSnap, is an AI-powered biopharma intelligence and drug discovery platform designed for life science professionals who need comprehensive, real-time insights to drive smarter R&D, business development, competitive intelligence, and IP management strategies. Trusted by over 1,000 life science innovators, Synapse aggregates billions of data points — spanning 98,000+ drugs and biologics, 46,000+ targets, 1.1 million+ clinical trials and results, 16 million+ scientific patents, 67 million+ literature records, 23,000+ deals, 14,000+ indications, and 1 million+ organizations — into a single, unified platform that eliminates guesswork from drug discovery.

Built specifically for biopharma professionals, Synapse delivers end-to-end competitive intelligence from early-stage discovery through regulatory approval, enabling teams to identify high-potential targets, monitor competitor pipelines, accelerate clinical decisions, and fast-track partnerships — all powered by AI that continuously scans the evolving landscape.

Core Use Cases

• R&D Acceleration: Accelerate development of next-generation therapeutics with deep R&D and clinical intelligence on emerging modalities, including antibody therapeutics, conjugated drugs, gene and cell therapies, and more.
• Business Development: Discover new partners and acquisition targets, identify untapped opportunities, and steer your portfolio to maximize ROI with real-time business and market intelligence.
• Competitive Intelligence: Identify market gaps and minimize risk with an integrated platform that monitors new players, alerts you to emerging threats, and keeps you ahead of competitors.
• IP Management: Strategically develop, manage, and protect your organization's IP by seamlessly connecting drugs to their underlying patents and extracting key innovation trends.

Key Platform Capabilities

• AI-enriched search: Discover patterns across diverse pharma datasets using natural language and ontology-based searching powered by AI to make faster, data-driven decisions.
• End-to-end discovery: Navigate the global R&D landscape with a 360° view of therapeutic pipelines from early-stage discovery to approval.
• Built for pharma: A single, integrated platform that connects deep R&D intelligence on drugs and their underlying IP in one place.
• Uncover untapped markets and monitor breakthroughs across diverse therapeutic areas including ADCs, RNA therapies, oncology, and obesity.
• Track competitors and receive alerts on emerging threats and new market entrants.
• Support portfolio planning, market landscaping, partnerships strategy, company due diligence, and enhanced team collaboration.

Flexible Subscription Plans

• Freemium: Start with essential tools and limited data access, including 5 searches per day, 5 entity comparisons, 5 uses of PatSnap Hiro daily, 100 data gathering instances per day for drugs, organizations, and competitive landscape analyses, and unlimited access to clinical trials, literature, and news.
• Premium: Unlimited daily searches, up to 1,000 email alerts, unlimited entity comparisons, 99 dashboard analysis uses, enhanced data access to drugs, organizations, patents, clinical results, deals, and translational medicine, plus full access to comprehensive analysis and export features.
• Enterprise: Enterprise-wide platform access, a Shared Workspace for seamless collaboration and workflow integration, and dedicated onboarding and support teams.

Synapse is part of the broader PatSnap Eureka platform ecosystem, which also includes tools for IP intelligence, biosequence search and analysis, and chemical structure search. The platform is designed to integrate into existing workflows and supports teams across R&D, business development, competitive intelligence, and IP functions within life sciences organizations.